Table of Content

Open Access iconOpen Access

ARTICLE

Triptolide Inhibits Breast Cancer Cell Metastasis Through Inducing the Expression of miR-146a, a Negative Regulator of Rho GTPase

Qin Liu*†, Wei Wang, Fangqiong Li, Dongyang Yu, Chunfen Xu*, Hongbing Hu*

* Department of Blood Transfusion, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China
† Department of Clinic Laboratory, Tongde Hospital of Zhejiang Province, Hangzhou, P.R. China
‡ Department of Clinic Laboratory, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China

Oncology Research 2019, 27(9), 1043-1050. https://doi.org/10.3727/096504019X15560124931900

Abstract

Triptolide, an extract of Tripterygium wilfordii, has been shown to have a potent anticancer activity. In the present study, it was found that triptolide could effectively induce apoptosis and inhibit proliferation and invasion in malignant MDA-MB-231 breast cancer cells. The study focused on its effect on inhibiting invasion, which has not been extensively reported to date. We predicted that triptolide may change invasion activity via microRNAs (miRNAs), which have been recognized as important regulators of gene expression. miRNAome variation in MDA-MB-231 cells with or without triptolide treatment demonstrated that miR-146a was upregulated following treatment with triptolide. Our previous studies have shown that miR-146a can inhibit migration and invasion by targeting RhoA in breast cancer. This time, we found that miR-146a can target Rac1, another key member of the Rho GTPase family. Luciferase reporter containing Rac1 3′-UTR was constructed to prove this hypothesis. In addition, following treatment with triptolide, the expression of RhoA and Rac1 was found to be decreased. These results indicated that triptolide exerts its anti-invasion activity through a miRNA-mediated mechanism, which indirectly regulates the expression of Rho GTPase. Triptolide combined with miR-146a could improve the effect of triptolide treatment on breast cancer.

Keywords


Cite This Article

APA Style
Liu, Q., Wang, W., Li, F., Yu, D., Xu, C. et al. (2019). Triptolide inhibits breast cancer cell metastasis through inducing the expression of mir-146a, a negative regulator of rho gtpase. Oncology Research, 27(9), 1043-1050. https://doi.org/10.3727/096504019X15560124931900
Vancouver Style
Liu Q, Wang W, Li F, Yu D, Xu C, Hu H. Triptolide inhibits breast cancer cell metastasis through inducing the expression of mir-146a, a negative regulator of rho gtpase. Oncol Res. 2019;27(9):1043-1050 https://doi.org/10.3727/096504019X15560124931900
IEEE Style
Q. Liu, W. Wang, F. Li, D. Yu, C. Xu, and H. Hu "Triptolide Inhibits Breast Cancer Cell Metastasis Through Inducing the Expression of miR-146a, a Negative Regulator of Rho GTPase," Oncol. Res., vol. 27, no. 9, pp. 1043-1050. 2019. https://doi.org/10.3727/096504019X15560124931900



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 595

    View

  • 476

    Download

  • 0

    Like

Share Link